Journal of Controversies in Biomedical Research 2015; 1(1):23-27.
Doi: http://dx.doi.org/10.15586/jcbmr.2015.7
Commentary
Reactive Oxygen Species in Disease: Rebuttal of a Conventional Concept
Luis Vitetta1,2, Samantha Coulson1,2, Anthony W Linnane1,2
1The University of Sydney, Sydney Medical School – Medical Sciences, Discipline of Pharmacology, Australia; 2Medlab Clinical Ltd., Sydney, Australia.
Abstract
The
production of intracellular reactive oxygen species and reactive
nitrogen species has long been proposed as leading to the random
deleterious modification of macromolecules (i.e., nucleic acids,
proteins) with an associated progressive development of the age
associated systemic diseases (e.g., diabetes, Parkinson’s disease) as
well as contributing to the ageing process. Superoxide
anion (hydrogen peroxide) and nitric oxide (peroxynitrite) comprise
regulated intracellular second messenger pro-oxidant systems, with
specific sub-cellular locales of production and are essential for the
normal function of the metabolome and cellular
electro-physiology. We have posited that the formation of
superoxide anion and its metabolic product hydrogen peroxide, and
nitric oxide, do not conditionally lead to random damage of
macromolecular species such as nucleic acids or proteins. Under
normal physiological conditions their production is intrinsically
regulated that is very much consistent with their second messenger
purpose of function. We further propose that the concept of
an orally administered small molecule antioxidant as a therapy to
abrogate free radical activity (to control oxidative stress) is a
chimera. As such we consider that free radicals are not a major
overwhelming player in the development of the chronic diseases or the
ageing process.
Received: 24 August 2015; Accepted after revision: 03 September 2015; Published: 07 September 2015.
Author for correspondence: Luis Vitetta, The University of Sydney, Sydney Medical School – Medical Sciences, Discipline of Pharmacology, Australia, E-mail: [email protected]
How
to cite: Vitetta
L, Coulson S, Linnane AW. Reactive Oxygen Species in Disease:
Rebuttal of a Conventional Concept. Journal of Controversies in
Biomedical Research 2015; 1(1):23-27. Doi: http://dx.doi.org/10.15586/jcbmr.2015.7
Licence: This open access article is licenced under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/
Introduction
Numerous
compounds that have been isolated from foods, nutrients and herbal medicines,
commonly defined as antioxidants, have been advanced as molecules that can effectively
counterbalance the over-production of free radicals produced by intracellular
oxidation reactions in the expectation of ameliorating symptoms of the chronic
diseases. It has been reported that the
body can function effectively with low levels of free radicals but if there is
an overload of reactive oxygen species (ROS) and or reactive nitrogen species
(RNS) that then there is an increased risk for diabetes, chronic kidney
disease, heart disease, cancer, and other chronic diseases. We have challenged
the antioxidant–free radical theory of chronic diseases and ageing and advanced
the idea that there is a critical requirement for free radicals that is
consistent with their intracellular second messenger functions (1-3), a fact
that is rarely acknowledged in such studies.
Antioxidant
supplements are among the most popular over-the-counter health products in the
world with a net worth of billions of dollars in global sales without the
requirement of a health practitioner’s prescription (4,5). The motivation for
this influx of high market value is largely based on in vitro research models
conducted to demonstrate that free radicals could be counterbalanced suggesting
that antioxidant compounds in foods and supplements could benefit health by
abrogating the over production of free radicals.
There
has been a plethora of investigations on antioxidants and the rescuing of the
asserted oxidative damage to macromolecules that ensues. However the
conclusions emanating from the in vitro and in vivo experimental models have no
relevance to normal physiological function and therefore the significance to
the risk of developing a chronic disease or affecting the ageing process is a
null effect (1). Hydrogen peroxide is
the immediately obvious substance employed in such investigations with
thousands of articles in the medical and scientific literature reporting it as
causal for macromolecular damage and severe cellular toxicity. The
demonstration of cellular toxicity is based on employing hydrogen peroxide
levels that far exceed those observed under normal physiological conditions,
otherwise it is cited that at lower levels the phenomenon is not detectable.
The hypothesis that is advanced and justified is that the high levels of
hydrogen peroxide are requisite in order to demonstrate the toxic effect that
hydrogen peroxide has on cells and its complement of macromolecules. Additional
experiments investigating the levels of cellular catalase and glutathione
peroxidase, which function to regulate the level of hydrogen peroxide, further
postulate that these enzyme systems prevent the cellular damage that hydrogen
peroxide may cause. In contrast to this, hydrogen peroxide is not a toxic
compound at physiological levels (1).
This
commentary discusses in brief the role of these second messengers in the
regulation of the metabolome in terms of radical formation as an essential
contributor to the physiologically normal regulation of sub-cellular bioenergy
systems; proteolysis regulation; transcription activation; enzyme activation;
mitochondrial DNA changes; redox regulation of metabolism and cell
differentiation (1).
Historical view and
contradictions
Historically,
Harman (6) in 1956 hypothesized that free radicals (also termed oxygen radical
formation) was a major injurious contributor to the ageing process and
degenerative diseases due to their attack on cell constituents (macromolecules
such as DNA, proteins, cell membranes) and connective tissues. An extensive set
of experiments followed that received strong support for the hypothesis that
free radicals were causal for oxidative damage. Boveris and Chance (7) in 1973
showed that large amounts of superoxide anions were generated by the
mitochondrial electron transport chain during the phase of oxidative
phosphorylation of the Kreb’s cycle, whereby complex I and II reduced coenzyme
Q10 and its oxidation by complex III. Furthermore, Chance and colleagues (8)
then reported in 1979 and estimated that 1-3% of inspired oxygen was converted
to ROS, which would indeed be toxic to cells. Chance’s experiments however,
were contradicted when Staniek and Nohl (9) in 2000 and St-Pierre and
colleagues (10) in 2002 demonstrated that intact normally respiring
mitochondria were not observed to produce high concentrations of ROS and that
the earlier extrapolations of superoxide anion and hydrogen peroxide were over
estimations by several orders of magnitude. Therefore, the high amounts of ROS
were not produced in physiologically normally respiring human mitochondria and
that the human cellular metabolome tightly regulates the production of
ROS/RNS. This then indicating that
oxidative damage did not occur unless the system was induced to do so in a
non-physiological experimental setting.
Is oxidative damage
involved in depressive disorder?
In
a recent review by Tobe (11), investigations on mitochondrial dysfunction and
oxidative damage in major depressive disorder were considered. The human
studies described in that review were based on brain imaging captured via
magnetic resonance imaging and post mortem histologic studies. It was suggested
that the decreased size of the brain, decreased glial cell density and neuronal
size linked with major depressive disorder, biopolar or schizophrenia were due
to oxidative stress. There was no scientific or mechanistic explanation that
confirmed this suggestion nor was it associated with a systemic overproduction
of free radicals. The basis of the discussion was reverted to animal studies,
which had established a non-physiological environment that was causal for
increased ROS production, inhibition of mitochondrial respiration and oxidative
DNA damage (12-14). Such investigations
reinforce and reiterate that oxidative damage does not occur under normal
physiological conditions. The cellular
damage alluded to in those investigations occurs in a set of experiments with
induced abnormal productions of ROS/RNS.
Is antioxidant therapy
beneficial?
Additional
recent experiments by others (15) have questioned the role of antioxidant
supplementations, suggesting that introduction of antioxidants may cause
antioxidant-induced stress whereby these compounds overwhelm the body’s free
radical production disrupting cellular redox balance. Many investigators report benefits of antioxidant
administration however there are only a few that question the possible harmful
effects (16). Free radicals have been designated and repeatedly reported as
largely harmful chemical entities and as such have a negative impact on
cellular metabolism and mitochondria and therefore are causal for
macromolecular oxidative damage (16). However, it has been reported that ROS
and RNS participate in specific functions and play an important role in signal
transduction in many physiological events (1-3, 9,10). ROS and RNS play a significant role in signal
transduction of cytokine receptors, tyrosine receptors, serine/threonine
kinases, G protein-coupled receptors, ion-channel linked receptors in response
to angiotension II, cytokines, glutamate, epidermal growth factor, vascular
endothelial growth factor, tumour necrosis factor alpha and platelet derived
growth factor (15, 16). Furthermore,
hydrogen peroxide is a known mitogen (1).
Villanueva
and Kross (15) form the argument that excess consumption of administered
antioxidants can overwhelm the cellular function of ROS / RNS and therefore
decrease their biological function within cells. This deleterious action then
goes on to interfere with the normal cellular processes and requirements by
disrupting biochemical and physiological activity required for normal cellular
function. They list nine trials indicating no effect from antioxidant
supplementation and six trials that found harmful effects from antioxidant
supplementation versus twelve that reported a benefit (15). This body of
evidence raises a further query and concern as to antioxidant supplementation
benefits versus safety.
The
question may not only be if antioxidant supplementation is beneficial or
detrimental but is there an antioxidant effect? What has been reported is that
antioxidants that are referred to in the literature can also be designated as
pro-oxidants, inducing the formation of hydrogen peroxide, a necessary
biochemical requisite for optimal cellular function. It would hence seem that
antioxidants promote healthy cellular metabolism by providing a regulated
oxido-reductase activity. Coenzyme Q10 is such an example. Coenzyme Q10 is a
key component of the oxidative phosphorylation section of energy production and
electron transport chain as well as other organelle oxido-reductase activity
(3). Coenzyme Q10 has been labeled as a strict antioxidant however it also has
a pro-oxidant function through the formation of superoxide anion and hydrogen
peroxide that is a major factor in its beneficial mode of activity (3).
Reprise
The
human metabolome is an expression of a finely tuned dynamic equilibrium, which
is comprised of thousands of anabolic and catabolic reactions and all cellular
systems are finely regulated. However, there is no perfect machine and
malfunctions can occur (1). If there is a small inappropriate leakage of free
radicals, the mitochondria or cell can be damaged and will go into apoptosis
(death) and cannot continue to function in a compromised state as suggested by
some authors (17,18). Currently, there are no blinded human clinical trials
establishing excessive systemic over production of reactive oxygen species as
the primary cause of aging or associated diseases (1).
The
canon belief that the production of ROS and RNS leads to random deleterious
modification of macromolecular species, mitochondria and cellular metabolism
and that oxidative damage is a major contributor to ageing and related systemic
diseases is untenable. Furthermore, the administration of antioxidants such as
vitamin A, C, E, compounds found in herbs or coenzyme Q10 that can ameliorate
oxidative stress is flawed. ROS and RNS are products of normal cellular
metabolism and are necessary for normal physiological functioning of the
organism.
Furthermore,
consider as an extreme malfunction of the superoxide anion/NO systems that are
often cited in support of the free radical damage theory. The first, is septic shock which affects a
small number of individuals arises from phagocytic cells over producing the
radicals consequent on a microbial infection that leads to an unrelenting and
life taking arterial hypotension unless the causative infection is
resolved. Secondly, the alternating view
is exemplified by chronic granulomatous disease, a rare immuno-deficiency
disease arising from a phox 67 mutation that is characterized by the inability
of neutrophils to adequately respond to a microbial infection. The cells of the
immune system under produce superoxide anion/nitric oxide and most patients die
from overwhelming infections at an early age as a result of the deficit.
Conclusion
Antioxidants
can also act as pro-oxidants (e.g. ascorbic acid) therefore readdressing the
action of these molecules to oxido-reductase molecules may serve researchers
with a more appropriate mode of action for further investigations of
efficacy. The antioxidant compounds
marketed still play a vital role and should be included in a prescription of
health. However, additional clinically
relevant research is required though, that considers that the evolutionary
progression of humans has become dependent upon the production of ROS and RNS
formation. Reassessment of the antioxidant theory and a new paradigm of thinking
are certainly required.
Conflict of Interest
Luis
Vitetta has received National Institute of Complementary Medicine and National
Health and Medical Research Council of Australia competitive funding and
Industry support for research into nutraceuticals and herbal medicines. The
authors declare no other potential conflicts of interest with respect to
research, authorship and/or publication of this article.
References
1. Linnane AW, Kios M, Vitetta L. Healthy
aging: Regulation of the metabolome by cellular redox modulation and prooxidant
signaling systems: The essential roles of superoxide anion and hydrogen
peroxide. Biogerontology 2007;8(5):445-467.
http://dx.doi.org/10.1007/s10522-007-9096-4
PMid:17415678
2. Linnane AW, M. Kios, Vitetta L. The
essential requirement for superoxide radical and nitric oxide formation for
normal physiological function and healthy aging. Mitochondrion 2007;7(1-2):1-5.
http://dx.doi.org/10.1016/j.mito.2006.11.009
PMid:17317335
3. Linnane AW, Kios M, Vitetta L. Coenzyme
Q(10)--its role as a prooxidant in the formation of superoxide anion/hydrogen
peroxide and the regulation of the metabolom. Mitochondrion 2007; 7:S51-61.
http://dx.doi.org/10.1016/j.mito.2007.03.005
PMid:17482887
4. Choices. 2011 Supplements who needs
them? NHS. June: 1-33.
5. Saeidnia S, Abdollahi M. Toxicological
and pharmacological concerns on oxidative stress and related diseases. Toxicol
Appl Pharmacol 2013;273(3):442-55.
http://dx.doi.org/10.1016/j.taap.2013.09.031
6. Harman D. Aging: a theory based on free
radical and radiation chemistry. J Gerontol. 1956;11(3):298-300.
http://dx.doi.org/10.1093/geronj/11.3.298
PMid:13332224
7. Boveris A, Chance B. The mitochondrial
generation of hydrogen peroxide. General properties and effect of hyperbaric
oxygen. Biochem J 1973;134(3):707-16.
http://dx.doi.org/10.1042/bj1340707
PMid:4749271 PMCid:PMC1177867
8. Chance B, Sies H, Boveris A.
Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59(3):527-605.
PMid:37532
9. Staniek K, Nohl H. Are mitochondria a
permanent source of reactive oxygen species? Biochim Biophys Acta
2000;460(2-3):268-75.
http://dx.doi.org/10.1016/S0005-2728(00)00152-3
10. St-Pierre J, Buckingham JA, Roebuck
SJ, Brand MD. Topology of superoxide production from different sites in the
mitochondrial electron transport chain. J Biol Chem 2002; 277(47):44784-90.
http://dx.doi.org/10.1074/jbc.M207217200
PMid:12237311
11. Tobe EH. Mitochondrial dysfunction,
oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat 2013;
9:567-73.
http://dx.doi.org/10.2147/NDT.S44282
PMid:23650447 PMCid:PMC3640606
12. Lee HM, Reed J, Greeley GH Jr,
Englander EW. Impaired mitochondrial respiration and protein nitration in the
rat hippocampus after acute inhalation of combustion smoke. Toxicol Appl
Pharmacol 235(2):208.
http://dx.doi.org/10.1016/j.taap.2008.12.010
PMid:19133281 PMCid:PMC2967486
13. Lee HM, Greeley GH, Herndon DN, Sinha
M, Luxon BA, Englander EW. A rat model of smoke inhalation injury: influence of
combustion smoke on gene expression in the brain. Toxicol Appl Pharmacol
2005;208(3):255-65.
http://dx.doi.org/10.1016/j.taap.2005.03.017
PMid:15893353
14. Lee HM, Greeley GH Jr., Englander EW. Transgenic
overexpression of neuroglobin attenuates formation of smoke-inhalation-induced
oxidative DNA damage, in vivo, in the mouse brain. Free Radic Biol Med 2011;
51(12):2281-7.
http://dx.doi.org/10.1016/j.freeradbiomed.2011.09.026
PMid:22001746 PMCid:PMC3241998
15. Villanueva C, Kross R.
Antioxidant-induced stress. Int J Mol Sci 2012; 13(2): 2091-109.
http://dx.doi.org/10.3390/ijms13022091
PMid:22408440 PMCid:PMC3292009
16. Valko M, Leibfritz D, Moncol J, Cronin
MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological
functions and human disease. Int J Biochem Cell Biol 2007;39(1):44-84.
http://dx.doi.org/10.1016/j.biocel.2006.07.001
PMid:16978905
17. Parikh SM. Therapeutic targeting of
the mitochondrial dysfunction in septic acute kidney injury. Curr Opin Crit
Care 2013;19(6):554-9.
http://dx.doi.org/10.1097/MCC.0000000000000038
18. Muyderman H, Chen.T. Mitochondrial
dysfunction in ALS - a valid pharmacological target? Br J Pharmacol
2014;171(8):2191-205.
http://dx.doi.org/10.1111/bph.12476